Structured management of adult cardiovascular risk factors in outpatient care
Official title: Effect of a Structured Clinical and Pharmacological Management Strategy on Cardiovascular Risk Factors in Adult Patients in Routine Clinical Practice: A Pseudo-Experimental Before-and-After Study
Run by Universidad Católica San Antonio de Murcia · NCT07447362 · Data updated 2026-11-12
This project will try a structured clinic approach to managing blood pressure, cholesterol, diabetes, and weight in adults with cardiovascular risk factors to see if it improves risk control and outcomes.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Universidad Católica San Antonio de Murcia Academic / other |
| Locations | 1 site (Santiago, Santiago Metropolitan) |
| Status | Recruiting |
| Started | July 24, 2024 |
| Main results expected | July 24, 2026 |
| Study ends | October 24, 2026 |
| Registry record updated | March 3, 2026 |
| Trial ID | NCT07447362 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who attend the outpatient cardiology clinic and have at least one cardiovascular risk factor (hypertension, diabetes, dyslipidemia, obesity, or smoking) and can give informed consent are ideal candidates.
✕Probably not a fit
Patients who are pregnant, require hospitalization for severe clinical instability, are on dialysis for end-stage renal disease, cannot complete follow-up visits, or refuse participation are unlikely to receive benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This before-and-after interventional project follows adults attending an outpatient cardiology clinic who have one or more cardiovascular risk factors. Patients receive standard cardiology care while clinical data are collected under a structured cardiovascular risk management program. Outcomes and risk-factor control before and after implementing the structured approach will be compared to identify predictors of adverse events and opportunities to optimize prevention. No experimental drugs are given and routine treatment is not altered by the protocol.
Why it matters
Potential benefit: If successful, the program could improve routine control of blood pressure, cholesterol, blood sugar, and weight and thereby reduce future heart attacks and strokes.
How similar studies have gone: Prior clinic-based, structured risk-management and quality-improvement programs have often produced modest to meaningful improvements in risk-factor control, so this approach builds on partially successful methods.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years * Presence of at least one cardiovascular risk factor (hypertension, diabetes, dyslipidemia, obesity, or smoking) * Receiving outpatient clinical follow-up * Ability to provide informed consent Exclusion Criteria: * Severe clinical instability requiring hospitalization * Pregnancy * End-stage renal disease or dialysis * Inability to complete follow-up visits * Refusal to participate
Where it's running
-
CDIEM Medical Center - Outpatient Cardiology Clinic
Santiago, Santiago Metropolitan, Chile Recruiting
Study contacts
- Study coordinator: Julio César Núñez Farías, MD, MSc (Cardiology)
- Email: llaillai@yahoo.es
- Phone: +56965860130
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Once-daily ASC30 to See if it helps adults with obesity or overweight and Type 2 diabetes
This study tests three daily doses of ASC30 against placebo in adults who are overweight or obese and have Type 2 diabetes to see if it helps with weight loss and safety over time.
-
Digital tool for doctors to prescribe exercise for people with cardiovascular risk factors
This project will test whether a new digital tool helps doctors create personalized exercise plans for adults with cardiovascular risk factors.
-
Postpartum program to prevent cardiometabolic problems after preeclampsia
This study will test a 9-month app-based support program to lower blood pressure and help with weight loss in first-time mothers who recently had preeclampsia.
-
Substituting high- with low-ultra-processed soy protein foods within a guideline-based diet for cardiometabolic health
This study tests whether a 12-week digital diet program with extra fruits and vegetables, combined with either low- or high-ultra-processed soy protein foods, can lower systolic blood pressure in adults with hypertension and obesity, about half of whom have type 2 diabetes.
-
Investigating body fat distribution and its impact on metabolic diseases in Japanese adults
This study looks at how the way body fat is distributed affects the risk of metabolic and heart diseases in Japanese adults.
-
Program to prevent young onset diabetes using genetic and clinical assessments
This study is testing a program that uses genetic and health checks to help young adults at risk of diabetes prevent the disease and learn more about their health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.